Pharmaceutical Tramadol Composition For Ophthalmic Use

Patent No. EP3348260 (titled "Pharmaceutical Tramadol Composition For Ophthalmic Use") was filed by Farmalider on Sep 5, 2016. The application was issued on Jun 2, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRATAGEMMar 2, 2022-
STRATAGEM INTELLECTUALMar 2, 2022-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3348260

FARMALIDER
Application Number
EP16843709A
Filing Date
Sep 5, 2016
Status
Opposition Rejected
Mar 29, 2024
Publication Date
Jun 2, 2021